Neurological biological science publishes positive data from the study of movement disorder (NBIX: NASDAQ)

Neurological Biological Sciences (Nasdak:NbixOn Thursday, it announced the results of the post -studies analysis of two studies that showed the effectiveness of the Exrezza capsules in adults between the ages of 65 years and over with the late movement defect, which is a movement disorder.

The data, published in the Journal of Clinical Psychiatry, showed that